DA
ABT icon

Drake & Associates’s Abbott ABT Stock Holding History

Drake & Associates’s Portfolio ABT Stock Details ABT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$665K Buy
7,330
+64
+0.9% +$5.84K 0.11% 60
2026
Q1 		$746K Sell
7,266
-64
-0.9% -$7.23K 0.14% 57
2025
Q4 		$918K Sell
7,330
-2,870
-28% -$366K 0.18% 61
2025
Q3 		$1.27M Buy
10,200
+3,711
+57% +$487K 0.27% 50
2025
Q2 		$883K Sell
6,489
-181
-3% -$23.9K 0.22% 50
2025
Q1 		$885K Sell
6,670
-102
-2% -$13K 0.25% 44
2024
Q4 		$874K Buy
6,772
+88
+1% +$10.2K 0.25% 46
2024
Q3 		$762K Buy
6,684
+154
+2% +$16.9K 0.25% 30
2024
Q2 		$679K Sell
6,530
-74
-1% -$7.85K 0.24% 29
2024
Q1 		$751K Sell
6,604
-100
-1% -$11.5K 0.27% 28
2023
Q4 		$738K Hold
6,704
– – 0.3% 27
2023
Q3 		$649K Sell
6,704
-99
-1% -$10.4K 0.29% 27
2023
Q2 		$742K Sell
6,803
-50
-0.7% -$5.33K 0.33% 26
2023
Q1 		$694K Buy
6,853
+122
+2% +$12.9K 0.34% 24
2022
Q4 		$739K Buy
+6,731
New +$697K 0.39% 20

Other funds holding ABT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Drake & Associates's ABT Position: Q2 2026 in Review

Drake & Associates increased its Abbott (ABT) stake by 0.88% in Q2 2026, buying an estimated $5.84K and bringing the position to 7,330 shares worth $665K. The position accounts for 0.11% of the portfolio, ranked #60.

Drake & Associates first reported a position in ABT in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.27M in Q3 2025. 2,950 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Drake & Associates held 7,330 shares of Abbott worth $665K as of Q2 2026.
  • Drake & Associates bought 64 Abbott shares in Q2 2026, an estimated $5.84K.
  • Abbott made up 0.11% of Drake & Associates's portfolio in Q2 2026, its #60 holding.
  • Drake & Associates first reported a position in Abbott in Q4 2022 and has held it in 15 quarters since.
  • Drake & Associates's Abbott position peaked at $1.27M in Q3 2025.
  • 2,950 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Drake & Associates's 13F filing for Q2 2026, filed 10 Aug 2026.